Amferia AB
559170-1262ActiveDeveloping peptide hydrogel technology to combat bacterial infections safely.
Biotechnology / Medical Device Company (SME)amferia.com
Yleiskatsaus
- 5–9
- Työntekijät
- 1–49t SEK
- Liikevaihto
- 2018
- Perustettu
Kuvaus
Amferia is a Swedish biotechnology company specializing in developing advanced antimicrobial solutions derived from fundamental research at Chalmers University of Technology. The core of their innovation is a patented peptide-hydrogel platform that safely utilizes antimicrobial peptides to kill near...
Tunnisteet
B2BPharmaceuticals
Avainsanat
Antibiotic Resistance